| Trial ID: | L5309 |
| Source ID: | NCT00815399
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Pioglitazone Versus Metformin in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Metformin
|
| Outcome Measures: |
Primary: Circulating Endothelial microparticles, six months | Secondary: Glucose profile, lipid profile, hemoglobin A1c, carotid intima-media thickness, six months
|
| Sponsor/Collaborators: |
Sponsor: University of Campania Luigi Vanvitelli
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
150
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-10
|
| Completion Date: |
2015-04
|
| Results First Posted: |
|
| Last Update Posted: |
2015-11-18
|
| Locations: |
Department of Geriatrics and Metabolic Diseases, Naples, 80138, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00815399
|
